Postural Orthostatic Tachycardia Syndrome: Symptoms, Diagnosis, and Understanding POTS

Postural Orthostatic Tachycardia Syndrome (POTS) is a condition that affects the autonomic nervous system, leading to a rapid increase in heart rate upon standing. This can result in a variety of symptoms, significantly impacting a person’s quality of life. As an expert in automotive repair at xentrydiagnosis.store, while POTS may seem outside my field, understanding complex systems and diagnostics is universally applicable. Just as we diagnose intricate car issues, diagnosing POTS requires a detailed understanding of its symptoms and diagnostic criteria.

Understanding the Diagnostic Criteria for POTS

The hallmark of POTS diagnosis is an abnormal increase in heart rate when transitioning from a lying down (supine) to a standing position. According to established diagnostic criteria, this is defined as:

Adults: An increase of 30 beats per minute (bpm) or more, or exceeding 120 bpm, within the first 10 minutes of standing.
Children and Adolescents: A more pronounced increase of 40 bpm or more is typically used as the diagnostic threshold.

It’s crucial to note that this heart rate increase occurs without a significant drop in blood pressure, which would indicate orthostatic hypotension instead.

Diagnostic Tests for POTS

While the heart rate criteria are central, diagnosing POTS often involves a combination of tests to confirm the condition and rule out other possibilities.

Active Stand Test: This simple bedside test mimics the heart rate response seen in POTS. It involves recording heart rate and blood pressure while lying down, and then at 2, 5, and 10-minute intervals after standing. While convenient, it’s important to understand that the Active Stand Test might not detect all cases of POTS. A negative result doesn’t definitively exclude POTS if symptoms are strongly suggestive.
Tilt Table Test: Considered the gold standard for POTS diagnosis, this test is conducted in a controlled medical setting. The patient is strapped to a table that is tilted to a head-up position (usually 60-70 degrees) while heart rate and blood pressure are continuously monitored. This test allows for a more detailed assessment of the body’s response to postural changes.

Doctors may also employ more specialized tests to further evaluate the autonomic nervous system and identify potential underlying issues contributing to POTS. These can include:

Quantitative Sudomotor Axon Reflex Test (QSART or Q-Sweat): Measures sweat production to assess the function of small nerve fibers.
Thermoregulatory Sweat Test (TST): Evaluates sweating patterns across the body in response to heat.
Skin Biopsies: Used to examine small nerve fibers and detect neuropathy, which is common in some POTS patients.
Gastric Motility Studies: Assess the function of the digestive system, as gastrointestinal issues are frequently reported in POTS.

Signs and Symptoms Beyond Heart Rate in POTS

POTS is more than just a fast heart rate. It’s a syndrome characterized by a wide array of symptoms that can significantly impact daily life. While the diagnostic criteria focus on heart rate, recognizing the broader symptom profile is essential for accurate diagnosis and effective management.

Common POTS symptoms include:

Lightheadedness and Dizziness: Often triggered by standing up, this is a hallmark symptom.
Fatigue: Persistent and debilitating tiredness is a frequent complaint.
Headaches: Can range from mild to severe and may be chronic.
Heart Palpitations: An awareness of rapid or forceful heartbeats.
Exercise Intolerance: Difficulty with physical activity due to symptom exacerbation.
Nausea: Feeling sick to the stomach, sometimes with vomiting.
Cognitive Impairment (“Brain Fog”): Difficulty concentrating, memory problems, and mental fatigue.
Tremulousness (Shaking): Involuntary trembling, often in the hands.
Syncope (Fainting) or Near-Syncope: Loss of consciousness or feeling like you are about to faint.
Coldness or Pain in Extremities: Poor circulation can lead to cold hands and feet, and pain in the limbs.
Chest Pain: Unexplained chest discomfort.
Shortness of Breath: Feeling breathless or having difficulty breathing.
Visual Disturbances: Blurred vision or seeing spots.

Alt text: A graphic illustrating common symptoms of Postural Orthostatic Tachycardia Syndrome (POTS), including dizziness, fainting, fatigue, palpitations, and cognitive issues, to aid in postural orthostatic tachycardia syndrome symptoms diagnosis.

A distinctive visual sign some POTS patients experience is a reddish-purple discoloration of the legs upon standing. This is thought to be due to blood pooling in the lower extremities as a result of poor blood vessel constriction. This color change typically resolves when returning to a reclined position.

Impact on Quality of Life and Disability

The severity of POTS symptoms varies greatly. Some individuals experience mild symptoms that allow them to maintain a relatively normal lifestyle. However, for many, POTS can be severely debilitating. The functional impairment associated with POTS has been compared by experts to conditions like chronic obstructive pulmonary disease (COPD) and congestive heart failure.

It’s estimated that approximately 25% of POTS patients are unable to work due to the severity of their symptoms, highlighting the significant disability POTS can cause. Research has shown that the quality of life for POTS patients is comparable to that of patients undergoing dialysis for kidney failure, underscoring the profound impact this syndrome has on daily living.

Prevalence and Historical Context of POTS

POTS is not a rare condition. Before the COVID-19 pandemic, it was estimated to affect 1 to 3 million Americans, and millions more worldwide. Alarmingly, experts believe the POTS population has doubled since the pandemic’s onset, possibly due to viral infections triggering or exacerbating the condition in susceptible individuals.

While the term “POTS” was formally introduced in 1993, the syndrome itself is not new. Historically, it has been recognized under various names, including DaCosta’s Syndrome, Soldier’s Heart, Mitral Valve Prolapse Syndrome, Neurocirculatory Asthenia, Chronic Orthostatic Intolerance, and Orthostatic Tachycardia. Importantly, past misconceptions wrongly attributed POTS to anxiety. Modern research has definitively shown that POTS is a physiological disorder of the autonomic nervous system and not a psychological condition. Advances in autonomic nervous system research over the last three decades have significantly improved our understanding of POTS.

Classifications of POTS

Researchers have categorized POTS in different ways to better understand its underlying mechanisms.

Primary vs. Secondary POTS: Dr. Blair Grubb classified POTS as “primary” (idiopathic) when no underlying medical condition is identified, and “secondary” when POTS is associated with another medical condition known to contribute to its symptoms.
High Flow vs. Low Flow POTS: Dr. Julian Stewart proposed classifying POTS based on blood flow in the lower limbs.
Characteristic-Based Classifications: POTS is also described based on prominent features, such as:
- Hypovolemic POTS: Characterized by low blood volume.
- Partial Dysautonomic or Neuropathic POTS: Associated with partial autonomic neuropathy.
- Hyperadrenergic POTS: Linked to elevated levels of norepinephrine, a stress hormone.

It’s important to recognize that these classifications are not mutually exclusive, and many POTS patients exhibit overlapping characteristics.

Who is Affected by POTS?

POTS can affect anyone, regardless of age, gender, or race. However, it is most frequently diagnosed in women of childbearing age, between 15 and 50 years old. While men and boys can also develop POTS, approximately 80% of those affected are female.

POTS and Anxiety: Separating Fact from Fiction

Despite overlapping symptoms like rapid heart rate and palpitations, POTS is not caused by anxiety. Unfortunately, POTS patients are often misdiagnosed with anxiety or panic disorder, leading to delays in proper diagnosis and treatment. It’s crucial to understand that POTS symptoms are real and physiologically based, significantly impacting a person’s ability to function. Research consistently shows that POTS patients are no more likely, and possibly even less likely, to suffer from anxiety or panic disorders compared to the general population. Mental health surveys further support this, showing similar results between POTS patients and national norms.

What Causes POTS? Uncovering the Heterogeneous Nature

POTS is considered a heterogeneous syndrome, meaning it has diverse underlying causes that result in a similar set of clinical symptoms. POTS itself is not a disease, but rather a collection of symptoms that frequently occur together – hence the “Syndrome” in POTS. Identifying the specific cause of POTS in each individual can be challenging, and in many cases, the precise underlying cause remains undetermined, leading to a diagnosis of Primary or Idiopathic POTS (meaning of unknown origin).

However, numerous underlying diseases and conditions are known to be associated with or cause POTS-like symptoms. These include:

Amyloidosis
Autoimmune Diseases (e.g., Autoimmune Autonomic Ganglionopathy, Sjogren’s Syndrome, Lupus, Sarcoidosis, Antiphospholipid Syndrome)
Chiari Malformation
Deconditioning
Delta Storage Pool Deficiency
Diabetes and pre-diabetes
Ehlers Danlos Syndrome
Genetic Disorders/Abnormalities
Infections (e.g., Mononucleosis, Epstein Barr Virus, Lyme Disease, Mycoplasma pneumoniae, Hepatitis C)
Multiple Sclerosis
Mitochondrial Diseases
Mast Cell Activation Disorders
Paraneoplastic Syndrome
Toxicity (alcoholism, chemotherapy, heavy metal poisoning)
Traumas, Pregnancy, or Surgery
Vaccinations
Vitamin Deficiencies/Anemia

Alt text: Image depicting the Active Stand Test, a method for postural orthostatic tachycardia syndrome symptoms diagnosis, showing a person standing while heart rate is monitored to detect abnormal increases indicative of POTS.

Treatment Strategies for POTS

Managing POTS requires a personalized approach, ideally guided by a physician experienced in treating autonomic disorders. Common treatment strategies include:

Increased Fluid Intake: Aiming for 2-3 liters of fluids daily to increase blood volume.
Increased Salt Consumption: Consuming 8,000 to 10,000 mg of salt per day to help retain fluid and raise blood pressure.
Compression Stockings: To improve blood circulation and reduce blood pooling in the legs.
Elevating the Head of the Bed: To help conserve blood volume.
Reclined Exercises: Activities like rowing, recumbent cycling, and swimming are better tolerated.
Healthy Diet: Eating a balanced diet to support overall health.
Avoiding Triggers: Identifying and avoiding substances and situations that worsen orthostatic symptoms (e.g., prolonged standing, heat, alcohol).
Medications: Various medications may be prescribed to manage symptoms, including Fludrocortisone, Beta Blockers, Midodrine, Clonidine, Pyridostigmine, Benzodiazepines, SSRIs, SNRIs, Erythropoietin, and Octreotide.

If an underlying cause of POTS is identified, addressing that underlying condition is a crucial part of treatment.

Prognosis and Long-Term Outlook for POTS

Currently, there is no cure for POTS. However, research suggests that some individuals experience symptom improvement over time. Long-term studies on POTS are ongoing, but with appropriate lifestyle modifications, exercise, diet, and medical management, many patients can achieve a significant improvement in their quality of life. If an underlying cause is treatable, POTS symptoms may even subside. While the prognosis is generally positive for many, it’s important to acknowledge that some individuals may not improve and could experience worsening symptoms over time.

A Mayo Clinic study following pediatric POTS patients over several years found that approximately 18% reported complete resolution of symptoms, and over half reported improvement, highlighting the possibility of positive long-term outcomes, particularly in younger patients.

For further information and support, consider exploring resources from Dysautonomia International and sharing the “10 Facts About POTS” flyer to raise awareness about this often misunderstood condition.

Sources

Postural Tachycardia Syndrome. Blair P. Grubb, Circulation. 2008; 117: 2814-2817.
National Institute of Health, Neurological Institute of Neurological Disorders and Stroke, Postural Tachycardia Syndrome Information Page.
The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management. Satish R Raj, MD MSCI, Indian Pacing Electrophysiol J. 2006 April-Jun; 6(2): 84-99.
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Autonomic Neuroscience: Basic and Clinical 161 (2011) 46-48.
Postural tachycardia in children and adolescents: what is abnormal? Singer W, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA, J Pediatr. 2012 Feb;160(2):222-6. Epub 2011 Oct 11.
Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety; Masuki S, Eisenach JH, Johnson C et al. Journal of Applied Physiology 2006; 102: 1134-42.
Experimental induction of panic-like symptoms in patients with postural tachycardia syndrome; Khurana RK, Clinical Autonomic Research 2006; 16: 371-7.
Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia. Schondorf R, Low PA; Neurology 1993 Jan;43(1):132-7.
Increased plasma angiotensin II in postural tachycardia syndrome (POTS) is related to reduced blood flow and blood volume. Stewart JM, Glover JL, Medow MS. Clin Sci (Lond). 2006 Feb;110(2):255-63.
Postural orthostatic tachycardia syndrome following Lyme disease. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP; Cardiol J. 2011;18(1):63-6.
Postural Orthostatic Tachycardia Syndrome Associated With Mycoplasma pneumoniae. Kasmani, Rahil MD, MRCP; Elkambergy, Hossam MD; Okoli, Kelechi MD, MRCP; Infectious Diseases in Clinical Practice: September 2009 – Volume 17 – Issue 5 – pp 342-343.
Dysautonomia in the joint hypermobility syndrome. Gazit Y, Nahir AM, Grahame R, Jacob G. Am J Med. 2003 Jul;115(1):33-40.
Platelet Delta Granule and Serotonin Concentrations Are Decreased in Patients with Postural Orthostatic Tachycardia Syndrome Presented at the 51st Annual Meeting of the American Society of Hematology, December 6, 2009.
Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Int J Med Sci, 2010 Mar 11;7:62-7.
Autonomic dysfunction presenting as orthostatic intolerance in patients suffering from mitochondrial cytopathy. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Clin Cardiol. 2010 Oct;33(10):626-9.
Iron insufficiency and hypovitaminosis D in adolescents with chronic fatigue and orthostatic intolerance. Antiel RM, Caudill JS, Burkhardt BE, Brands CK, Fischer PR. South Med J. 2011 Aug;104(8):609-11.
Autonomic function tests in cases of chronic severe anaemia. Nand N, Mohan R, Khosla SN, Kumar P. J Assoc Physicians India. 1989 Aug;37(8):508-10.
Postural tachycardia syndrome after vaccination with Gardasil. Blitshteyn, Svetlana. European Journal of Neurology; 2010; Letter to the Editor
Orthostatic intolerance and syncope associated with Chiari type I malformation. Prilipko, O. et al. J Neurol Neurosurg Psychiatry 2005;76:1034-1036.
Long-term outcomes of adolescent-onset postural orthostatic tachycardia syndrome. S.J. Kizilbash, S.P. Ahrens, R. Bhatia, J.M. Killian, S. A. Kimmes, E.E. Knoebel, P. Muppa, A.L. Weaver, P.R. Fischer. Clin. Auton. Res. October 2013. Abstract presented at the 24th International Symposium on the Autonomic Nervous System.
Estimation of sleep disturbances using wrist actigraphy in patients with postural tachycardia syndrome. Bagai K1, Wakwe CI, Malow B, Black BK, Biaggioni I, Paranjape SY, Orozco C, Raj SR. Auton Neurosci. Oct 2013; 177(2): 260?265.
POTS – A World Tour, lecture presented by Dr. Satish Raj during the 2013 Dysautonomia International Conference.
Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). Schofield J1, Blitshteyn S, Shoenfeld Y, Hughes G. Lupus. 2014 Feb 25.